Coccidiosis Treatment Market - Forecast(2023 - 2028)

Report Code: HCR 0622 Report Format: PDF + Excel

Coccidiosis Treatment Market Overview

Coccidiosis Treatment Market size is estimated to reach $2.4 billion by 2027, growing at a CAGR of 3.6% during the forecast period 2022-2027. Coccidiosis is an ailment of birds and mammals that essentially influences the intestines, brought about by coccidia. Coccidiosis treatment involves the natural growth of immunity to coccidiosis which may advance during the application of anticoccidials in the feed. Toxoplasma gondii, brings about coccidiosis in cats and can bring about abortion in sheep, goats, and people. Sheep and goats act as an intermediate host for Toxoplasma gondii. Toxoplasmosis is a typical cause of abortions in ewes and does in the U.S. Toxoplasma gondii and associated coccidians are intracellular protozoan parasites. Coccidia is obligate intracellular parasites usually discovered in the intestinal tract. It could be demonstrated that replicated application of sulfonamides, provided that the suitable time period subsequent to infection is covered, can principally be utilized to curb piglet coccidiosis. However, the quantity of work needed is significant, and the practicability is low.

The surging acceptance of exhaustive farming techniques and proliferating demand for meat proteins fuelling meat generation in developed countries are set to drive the Coccidiosis Treatment Market. The boost in the government spending on poultry in numerous countries across the world and the rising pervasiveness of ailments like coccidiosis and toxoplasmosis are set to propel the growth of the Coccidiosis Treatment Market during the forecast period 2022-2027. This represents the Coccidiosis Treatment Industry Outlook.

Report Coverage

The report: Coccidiosis Treatment Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Coccidiosis Treatment Market.

By Drug Type: Ionophore Drugs, Antibiotic Drugs, Chemical Derivative Drugs.
By Infected Animal Species: Swine, Poultry, Companion Animals, Fish, Cattle.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America Coccidiosis Treatment Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the enormous demand for meat food and related products and the proliferating count of poultry and companion animals together with the growing predominance of coccidian ailments including toxoplasmosis in the North American region.
  • Coccidiosis Treatment Market growth is being driven by the increasing predominance of coccidian diseases amidst poultry and companion animals including toxoplasmosis and the expanding population and per capita intake of meat. However, the rising food safety concerns and augmenting meat prices worldwide are some of the major factors hampering the growth of Coccidiosis Treatment Market. 
  • Coccidiosis Treatment Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Coccidiosis Treatment Market report.

Coccidiosis Treatment Market: Market Share (%) by Region, 2021

For More Details on This Report - Request for Sample

Coccidiosis Treatment Market Segment Analysis – By Drug Type:

The Coccidiosis Treatment Market based on drug type can be further segmented into Ionophore Drugs, Antibiotic Drugs, and Chemical Derivative Drugs. The Ionophore Drugs Segment held the largest market share in 2021. This growth is owing to the surging application of ionophore drugs for the avoidance of coccidiosis owing to the broad-spectrum activity against most of the pathogenic species causing coccidian diseases and the dearth of development of medication resistance. Toxoplasmosis is a usual cause of abortions in ewes and does in the U.S. The soaring inclusion of ionophore drugs in starter and grower feeds is further propelling the growth of the Ionophore Drugs segment.

Furthermore, the Ionophore Drugs segment is estimated to grow with the fastest CAGR of 4.7% during the forecast period 2022-2027 owing to the soaring application of ionophore medications like lasalocid being extensively utilized as a veterinary medication against coccidiosis apart from other ailments like toxoplasmosis bringing about abortions in ewes and does in the U.S.

Coccidiosis Treatment Market Segment Analysis – By Infected Animal Species:

The Coccidiosis Treatment Market based on infected animal species can be further segmented into Swine, Poultry, Companion Animals, Fish, and Cattle. The Poultry segment held the largest market share in 2021. This growth is owing to the increased demand for meat worldwide. Toxoplasmosis is a usual cause of abortions in ewes and does in the U.S. Typical symptoms of coccidiosis in poultry include loss of weight and droopiness. The proliferating awareness regarding different treatment alternatives pertaining to coccidiosis is further propelling the growth of this segment.

Furthermore, the Swine segment is estimated to grow with the fastest CAGR of 4.2% during the forecast period 2022-2027 owing to the rising pervasiveness of coccidiosis in pigs typically brought about by Isospora suis and coccidiosis brings about diarrhoea in preweaning pigs with the replicated application of sulfonamides to curb piglet coccidiosis .

Coccidiosis Treatment Market Segment Analysis – By Geography:

The Coccidiosis Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Coccidiosis Treatment Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the increasing predominance of coccidiosis in food-producing animals and companion animals apart from toxoplasmosis in the U.S. in the North American region. The soaring progress in veterinary healthcare is further propelling the growth of the Coccidiosis Treatment Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the rising pervasiveness of coccidiosis in food-producing animals and companion animals in the Asia-Pacific region. Coccidia is obligate intracellular parasites typically discovered in the intestinal tract. The soaring demand for meat proteins in countries like China, India, and Malaysia is further fuelling the progress of the Coccidiosis Treatment Market in the Asia-Pacific region.

Coccidiosis Treatment Market Drivers

Surging Applications Of Anticoccidial Drugs Programs In Poultry Are Projected To Drive The Growth Of the Coccidiosis Treatment Market:

Apart from toxoplasmosis which typically brings about abortions in ewes and does in the U.S., coccidiosis is the rare ailment of poultry for which rare anticoccidial drugs are available and it is correctable by preventive programs also at the time of the outbreak in the field. Coccidiosis is an intestinal ailment brought about by protozoa. It most frequently is visible in chicks three to six weeks of age. The worst cases happen at four to five weeks. There are three principal goals of Anticoccidial drug programs in poultry. They are targeted to generate the maximum growth and feed effectiveness with the least cost and ailment in broilers. The second goal is to establish persistent immunization for lengthier periods of time in layers or breeders. The third goal is to prevent anticoccidial drug resistance in the field and decrease medication costs. The selection of a product or program may rely on the season of the year or other factors which influence exposure to the coccidial population. Frequently, a single product will be utilized from day one to slaughter, or with a withdrawal period of 3–7 days. Nearly all products are authorized for application until slaughter. The application of one product in the starter feed and another in the grower feed for the purpose of avoidance and regulation of coccidiosis is termed a shuttle program in the U.S. and a dual program in additional countries. These programs are mostly utilized for industrial purposes where bigger poultry feed production is operated. The surging applications of anticoccidial drug programs in poultry are therefore fuelling the growth of the Coccidiosis Treatment Market during the forecast period 2022-2027.

Proliferating Applications Of Herbal Antidotes For Coccidiosis Are Expected To Boost The Demand For Coccidiosis Treatment:

Apart from toxoplasmosis which usually causes abortions in ewes and does in the U.S., coccidiosis is the blight of the poultry industry bringing about significant economic loss. Eimeria species are termed as protozoan parasites to bring about morbidity and demise in poultry. Over 300,000 species of flowering plants have been reported globally. To date, less than 1% of them have been investigated for application against protozoan ailments. A. annua and its component active compound artemisinin have been recorded to possess anticoccidial action. The extract from the bark of the pine tree (Pinus radiata), which is abundant in condensed tannins, was recorded to restrict the life cycle of Coccidia as proved by reduced sporulation of the oocysts of E. tenella, E. maxima, and E. acervuline. Green tea extracts have been demonstrated to considerably restrict the sporulation process of coccidian oocysts. Correspondingly, the selenium and polyphenolic compounds in green tea are thought to be active compounds to inactivate the enzymes accountable for coccidian sporulation. The proliferating applications of herbal antidotes for coccidiosis regulation are therefore driving the growth of the Coccidiosis Treatment Market during the forecast period 2022-2027.

Coccidiosis Treatment Market Challenges

Disadvantages Of Coccidiostatics, Antibiotic-Based Coccidiosis Regulation, And Antibiotic Free Chains Are Hampering The Growth Of The Coccidiosis Treatment Market:

Coccidiostatics have disadvantages like coccidia being the simplest parasite that consistently adjusts to medications utilized against them. Owing to them, there may be paresis of muscles on the legs of turkey poults. Even with exacting adherence to the dosage, there is a likelihood of poisoning with medications. There could be probable bleeding in the gastrointestinal tract of turkey poultry. Vaccine- and antibiotic-based techniques for curbing coccidiosis have numerous limitations. Consumers and governments are increasingly demanding a decrease in antibiotic application in poultry. In Antibiotic Free (AF) chains, the average mortality rate is 5.5% as reported in 2019, against 3-3.5% in regular production. These issues are thus hampering the growth of the Coccidiosis Treatment Market.

Coccidiosis Treatment Industry Outlook:

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Coccidiosis Treatment Market. Key companies of this market are:

  1. Vetoquinol SA
  2. Zoetis, Inc.
  3. Huvepharma
  4. Smartvet Inc.
  5. Boehringer Ingelheim Vetmedica, Inc.
  6. Merck Animal Health
  7. Intas Pharmaceuticals Ltd
  8. Elanco Incorporated 
  9. Merial
  10. F. Hoffmann-La Roche AG

Recent Developments

  • In April 2022, Vetoquinol declared that Felpreva is presently accessible for veterinarians to prescribe in five European markets involving France, Germany, the United Kingdom, Austria, and Italy. Felpreva is a leading-edge innovation in companion animal parasitology. It is the earliest in order three-monthly spot-on parasiticide for cats that covers tapeworms additionally to other endoparasites (lungworms, roundworms, and hookworm) and ectoparasites (fleas, ticks, and mites) in a single dose.
  • In October 2020, it was reported that Huvepharma generated Monimax®, an approved coccidiosis control solution marketed in numerous regions across the world, has presently acquired EU approval. Huvepharma began marketing Monimax® in 2012 external to the EU as part of its worldwide rollout, which permitted Huvepharma to utilize the product ahead of the European kickoff. The European kickoff, of course, concurred with the worldwide COVID-19 pandemic, and like nearly every enterprise in the world, there were related challenges.
  • In September 2020, Zoetis declared the introduction of Vetscan Imagyst™, a diagnostic platform that utilizes an integration of image recognition technology, algorithms, and cloud-based artificial intelligence (AI) to convey precise testing outcomes to the clinic. Imagyst’s earliest indication will be for testing fecal samples for parasites, and it has the potential for expansive applications to distinct kinds of testing in the future. Imagyst was established to initially assist veterinarians to make precise and timely point-of-care intestinal parasitic diagnoses for dogs and cats.

Related Reports

Poultry Diagnostics Market - Industry Analysis, Market Size, Share, Trends,Application Analysis, Growth and Forecast 2021 - 2026

Report Code: HCR 40278

Poultry Processing Equipment Market - Forecast(2022 - 2027)

Report Code: FBR 54406

US Poultry Market Data Review (2016 - 2027)

Report Code: IMFBR 0006 

For more Lifesciences and Healthcare Market reports, please click here

1. Coccidiosis Treatment Market Overview
    1.1 Definitions and Scope
2. Coccidiosis Treatment Market - Executive Summary
3. Coccidiosis Treatment Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Coccidiosis Treatment Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Coccidiosis Treatment Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Coccidiosis Treatment Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Coccidiosis Treatment Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Coccidiosis Treatment Market – By Drug Type (Market Size –$Million/$Billion) 
    8.1 Ionophore Drugs
    8.2 Antibiotic Drugs
    8.3 Chemical Derivative Drugs
9. Coccidiosis Treatment Market – By Infected Animal Species (Market Size –$Million/$Billion) 
    9.1 Swine
    9.2 Poultry
    9.3 Companion Animals
    9.4 Fish
    9.5 Cattle
10. Coccidiosis Treatment Market - By Geography (Market Size -$Million/Billion)
    10.1 North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 Germany
        10.2.2 France
        10.2.3 UK
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Chile
        10.4.4 Colombia
        10.4.5 Rest of South America
    10.5 Rest Of The World
        10.5.1 Middle East
        10.5.2 Africa
11. Coccidiosis Treatment Market - Market Entropy
    11.1 New product launches
    11.2 M&A's, collaborations, JVs and partnerships
12. Coccidiosis Treatment Market – Industry Competition Landscape (Premium)
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key Companies
        12.1.3 Market Share by Countries – Key Companies
    12.2 Competition Matrix
    12.3 Best Practices for Companies
13. Coccidiosis Treatment Market – Key Company List by Country Premium (Premium)
14. Coccidiosis Treatment Market - Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"